Winterlight Labs Raises $5.6M in Series A Funding

Ontario Industry Updates
Written By Guest User
0.png

Winterlight Labs Inc., a company that is developing a proprietary AI technology to identify possible cognitive or functional changes in patients, has raised $5.6 million in new funding. The funding round was led by Hikma Ventures.

Winterlight will use the new funding to extend its technology to additional indications, such as schizophrenia and multiple sclerosis, as well as additional languages.

“Our ultimate goal is to help patients get better sooner by objectively measuring response to therapy in the real world through speech,” said Liam Kaufman, Co-Founder and CEO of Winterlight.

Guest User
Previous

2020 OBIO Capital Access Advisory Program - Call for Applications
Next

NERv Technology Wins Entrepreneurship World Cup and $500k Prize